phenol has been researched along with Clasp-Knife Spasticity in 57 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Significant improvements in gait variables of velocity and cadence were noted in children with cerebral palsy after BTX-A injections as compared with the phenol block group." | 7.72 | Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy. ( Chen, CL; Chen, CP; Chen, MJ; Chou, SW; Chung, CY; Wong, AM, 2004) |
| "Because acquired spasticity is dynamic and usually improves slowly, a temporary treatment method used to ameliorate increased muscle tone is desirable." | 6.39 | Treatment of acquired muscle spasticity using phenol peripheral nerve blocks. ( Abrams, RA; Bodine-Fowler, SC; Botte, MJ, 1995) |
| "She exhibited mild to moderate spasticity during the exam." | 5.39 | Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. ( Bruera, E; Fu, J; Ngo, A; Shin, K, 2013) |
| "To investigate the safety of single and repeated multilevel injections of botulinum toxin (BoNT) alone or a combination of phenol and BoNT performed under general anesthesia in children with chronic muscle spasticity." | 3.74 | Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. ( Ajizian, SJ; Kolaski, K; Koman, LA; Passmore, L; Pasutharnchat, N; Smith, BP, 2008) |
| "Significant improvements in gait variables of velocity and cadence were noted in children with cerebral palsy after BTX-A injections as compared with the phenol block group." | 3.72 | Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy. ( Chen, CL; Chen, CP; Chen, MJ; Chou, SW; Chung, CY; Wong, AM, 2004) |
| "To describe the specific techniques and adverse reactions of using concurrent, multiple injections of both botulinum toxin and phenol to manage spasticity in children with cerebral palsy (CP) and other neurologic conditions." | 3.72 | Combining botulinum toxin and phenol to manage spasticity in children. ( Gooch, JL; Patton, CP, 2004) |
| "The available studies on spasticity treatment offer some insight to guide clinical practice but are of variable methodological quality." | 2.53 | Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper. ( Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P, 2016) |
| "While in some children, spasticity may adversely impact the motor abilities, in others, it may help maintain posture and ability to ambulate." | 2.43 | Pharmacologic interventions for reducing spasticity in cerebral palsy. ( Patel, DR; Soyode, O, 2005) |
| " Consensus dosing guidelines have been developed and are presented within." | 2.42 | Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. ( Tilton, AH, 2003) |
| "Because acquired spasticity is dynamic and usually improves slowly, a temporary treatment method used to ameliorate increased muscle tone is desirable." | 2.39 | Treatment of acquired muscle spasticity using phenol peripheral nerve blocks. ( Abrams, RA; Bodine-Fowler, SC; Botte, MJ, 1995) |
| "Phenol blocks are a temporizing procedure during the phase of neurologic recovery." | 2.37 | Current status of functional lower extremity surgery in adult spastic patients. ( Jordan, C, 1988) |
| "Techniques to temporarily reduce spasticity include the implantation of a MicroPort reservoir and catheter for repeated branchial plexus blocks and phenol nerve blocks, which provide longer lasting relief of noxious muscle tone." | 2.37 | Management of the spastic upper extremity in the neurologically impaired adult. ( Keenan, MA, 1988) |
| "After injection, triceps spasticity and shoulder pain were immediately reduced, and abnormal positions of shoulder girdle complex and elbow joint gradually returned to functional limits over 2 weeks." | 1.51 | Phenol Neurolysis for the Management of Shoulder Spasticity in Early Recovery From Traumatic Brain Injury: A Case Report. ( DiTommaso, C; Li, S; Mas, MF, 2019) |
| "After treatment of the adductor spasticity by obturator nerve block the patient achieved an upright standing position with a walker." | 1.40 | Ultrasonographically guided obturator nerve block for bilateral adductor spasticity in a paraplegic patient. ( Akyuz, M; Ilgu, O; Ozer, NB; Yalcin, E, 2014) |
| "She exhibited mild to moderate spasticity during the exam." | 1.39 | Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. ( Bruera, E; Fu, J; Ngo, A; Shin, K, 2013) |
| "Pain, spasticity and hygiene were evaluated and the hip abduction range of motion (ROM) was measured at the end of the first week and in the first, second and third months following the intervention." | 1.36 | Neurolytic phenol blockade of the obturator nerve for severe adductor spasticity. ( Akkaya, T; Alptekin, A; Cakci, A; Gumus, HI; Umay, E; Unlu, E, 2010) |
| "In addition, mean hip adductor spasticity decreased significantly after ON neurolysis (P<0." | 1.36 | The effects of phenol neurolysis of the obturator nerve on the distribution of buttock-seat interface pressure in spinal cord injury patients with hip adductor spasticity. ( Alaca, R; Balaban, B; Taşkaynatan, MA; Tok, F; Yaşar, E; Yilmaz, B, 2010) |
| "Severe bilateral leg spasticity can cause severe symptoms and reduced quality of life in affected individuals." | 1.35 | Intrathecal phenol: an old treatment revisited. ( Bhakta, B; Kodavali, K; Pinder, C, 2008) |
| "Twenty-nine patients showing spastic limb were controlled by 53 intraneural injections of chemical agents, either lidocaine or phenol." | 1.35 | Percutaneous chemical nerve block with ultrasound-guided intraneural injection. ( Lee, J; Lee, YS, 2008) |
| "Phenol is a chemical agent which has been used for spasticity treatment for a long time." | 1.33 | A comparison of the effect of doxorubicin and phenol on the skeletal muscle. May doxorubicin be a new alternative treatment agent for spasticity? ( Alparslan, B; Culhaci, N; Cullu, E; Ozkan, I, 2005) |
| "The management of spasticity should be implemented with the most appropriate pharmacologic agents." | 1.32 | Temporospatial parameters of gait after obturator neurolysis in patients with spasticity. ( Esquenazi, A; Hirai, B; Ofluoglu, D, 2003) |
| "One patient had recurrence of spasticity requiring a second surgical procedure (split anterior tibial tendon transfer), and two patients had significant toe clawing at final follow-up." | 1.28 | The use of open phenol blocks to the motor branches of the tibial nerve in adult acquired spasticity. ( Anderson, RB; Moore, TJ, 1991) |
| "Two patients with spastic hemiplegic shoulder showed reduction in pain and immediate improvement in external rotation, abduction, and flexion after phenol motor point blocks to the subscapularis muscle." | 1.28 | Subscapularis motor point block for the painful hemiplegic shoulder. ( Chironna, RL; Hecht, JS, 1990) |
| "The motor points of spastic wrist and finger flexors were identified using a nerve stimulator." | 1.27 | Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults. ( Garland, DE; Keenan, MA; Lilling, M, 1984) |
| "Thirty-nine adults with acquired spastic disorders who had 21 phenol injections and 21 neurectomies of the motor branch of the ulnar nerve in Guyon's canal for control of intrinsic spasticity in the hand were reviewed." | 1.27 | Management of intrinsic spasticity in the hand with phenol injection or neurectomy of the motor branch of the ulnar nerve. ( Botte, M; Henderson, R; Keenan, MA; Todderud, EP, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (28.07) | 18.7374 |
| 1990's | 10 (17.54) | 18.2507 |
| 2000's | 16 (28.07) | 29.6817 |
| 2010's | 13 (22.81) | 24.3611 |
| 2020's | 2 (3.51) | 2.80 |
| Authors | Studies |
|---|---|
| Alfaro, A | 2 |
| Karri, J | 1 |
| Zhang, B | 1 |
| Li, S | 2 |
| Matsumoto, ME | 1 |
| Berry, J | 1 |
| Yung, H | 1 |
| Matsumoto, M | 1 |
| Munin, MC | 1 |
| Demir, Y | 1 |
| Şan, AU | 1 |
| Kesikburun, S | 1 |
| Yaşar, E | 2 |
| Yılmaz, B | 2 |
| Mas, MF | 1 |
| DiTommaso, C | 1 |
| Graham, LA | 1 |
| Fu, J | 2 |
| Ngo, A | 1 |
| Shin, K | 1 |
| Bruera, E | 2 |
| Yalcin, E | 1 |
| Akyuz, M | 1 |
| Ilgu, O | 1 |
| Ozer, NB | 1 |
| Lui, J | 1 |
| Sarai, M | 1 |
| Mills, PB | 1 |
| Ploypetch, T | 1 |
| Kwon, JY | 1 |
| Armstrong, HF | 1 |
| Kim, H | 1 |
| Otero-Romero, S | 1 |
| Sastre-Garriga, J | 1 |
| Comi, G | 1 |
| Hartung, HP | 1 |
| Soelberg Sørensen, P | 1 |
| Thompson, AJ | 2 |
| Vermersch, P | 1 |
| Gold, R | 1 |
| Montalban, X | 1 |
| Kolaski, K | 1 |
| Ajizian, SJ | 1 |
| Passmore, L | 1 |
| Pasutharnchat, N | 1 |
| Koman, LA | 1 |
| Smith, BP | 1 |
| Elovic, EP | 1 |
| Esquenazi, A | 4 |
| Alter, KE | 1 |
| Lin, JL | 1 |
| Kaelin, DL | 1 |
| Akkaya, T | 1 |
| Unlu, E | 1 |
| Alptekin, A | 1 |
| Gumus, HI | 1 |
| Umay, E | 1 |
| Cakci, A | 1 |
| Yelnik, AP | 2 |
| Simon, O | 1 |
| Bensmail, D | 1 |
| Chaleat-Valayer, E | 1 |
| Decq, P | 1 |
| Dehail, P | 1 |
| Quentin, V | 1 |
| Marque, P | 1 |
| Parratte, B | 1 |
| Pellas, F | 1 |
| Rousseaux, M | 1 |
| Trocello, JM | 1 |
| Uzzan, M | 1 |
| Dumarcet, N | 1 |
| Tok, F | 1 |
| Taşkaynatan, MA | 1 |
| Balaban, B | 1 |
| Alaca, R | 1 |
| Mayer, N | 1 |
| Lee, S | 1 |
| Brashear, A | 1 |
| Elovic, E | 1 |
| Francisco, GE | 1 |
| Yablon, S | 1 |
| Gutiérrez, C | 1 |
| Guo, Y | 1 |
| Palla, S | 1 |
| Jarrett, L | 1 |
| Nandi, P | 1 |
| Tilton, AH | 1 |
| JERVELL, J | 1 |
| PEDERSEN, E | 1 |
| JUUL-JENSEN, P | 1 |
| KOPPANG, K | 1 |
| LOURIE, H | 1 |
| VANASUPA, P | 1 |
| KHALILI, AA | 1 |
| HARMEL, MH | 1 |
| FORSTER, S | 1 |
| BENTON, JG | 1 |
| LIVERSEDGE, LA | 1 |
| MAHER, RM | 1 |
| Ofluoglu, D | 1 |
| Hirai, B | 1 |
| Cormack, J | 1 |
| Powers, CM | 1 |
| Wong, AM | 1 |
| Chen, CL | 1 |
| Chen, CP | 1 |
| Chou, SW | 1 |
| Chung, CY | 1 |
| Chen, MJ | 1 |
| McCrea, PH | 1 |
| Eng, JJ | 1 |
| Willms, R | 1 |
| Gooch, JL | 1 |
| Patton, CP | 1 |
| Mayer, NH | 1 |
| Cullu, E | 1 |
| Ozkan, I | 1 |
| Culhaci, N | 1 |
| Alparslan, B | 1 |
| Patel, DR | 1 |
| Soyode, O | 1 |
| Pinder, C | 1 |
| Bhakta, B | 1 |
| Kodavali, K | 1 |
| Lee, J | 1 |
| Lee, YS | 1 |
| Wainapel, SF | 1 |
| Haigney, D | 1 |
| Labib, K | 1 |
| Garland, DE | 1 |
| Lilling, M | 1 |
| Keenan, MA | 4 |
| Leduc, B | 1 |
| Botte, MJ | 2 |
| Abrams, RA | 1 |
| Bodine-Fowler, SC | 1 |
| Loubser, PG | 1 |
| Barnes, MP | 1 |
| Greenbaum, MG | 1 |
| Young, MA | 1 |
| Frank, JM | 1 |
| Ward, KA | 1 |
| Geller, AS | 1 |
| Gündüz, S | 1 |
| Kalyon, TA | 1 |
| Dursun, H | 1 |
| Möhür, H | 1 |
| Bilgiç, F | 1 |
| Moore, TJ | 1 |
| Anderson, RB | 1 |
| Morrison, JE | 1 |
| Matthews, D | 1 |
| Washington, R | 1 |
| Fennessey, PV | 1 |
| Harrison, LM | 1 |
| Chironna, RL | 1 |
| Hecht, JS | 1 |
| Jordan, C | 1 |
| Todderud, EP | 1 |
| Henderson, R | 1 |
| Botte, M | 1 |
| Gibson, II | 1 |
| Kiwerski, J | 1 |
| Ackerman, WE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of EXOPULSE Mollii Suit on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis.[NCT05912595] | 36 participants (Anticipated) | Interventional | 2023-05-18 | Recruiting | |||
| Dynamic Splinting for Excessive Plantarflexion in Patients With Spastic Hemiplegia: A Randomized, Controlled Study of Gait Analysis[NCT01329705] | 0 participants (Actual) | Interventional | 2011-05-31 | Withdrawn | |||
| The Effect of Muscle Selection for Botulinum Toxin A Injection on the Treatment Outcome in Poststroke Elbow Flexor Spasticity[NCT04036981] | 55 participants (Actual) | Observational | 2019-05-10 | Completed | |||
| Assesment of Post-stroke Elbow Flexor Spasticity in Response to Passive Stretch in Different Forearm Positions[NCT03563209] | 60 participants (Actual) | Observational | 2018-03-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
According to the Modified Tardieu Scale, the difference between the angle of slow passive motion and the angle of muscle reaction represents the dynamic component of spasticity (spasticity angle) in degree. A big difference suggests spasticity while the low difference suggests muscular contracture. In this study, dynamic component of spasticity (spasticity angle) at forearm pronation, neutral position and supination was evaluated separately. (NCT03563209)
Timeframe: 1 day (Only one measurement was performed in time (cross-sectional))
| Intervention | degree (Median) |
|---|---|
| Spasticity Angle in Pronation | 70 |
| Spasticity Angle in Neutral Position | 60 |
| Spasticity Angle in Supination | 57.5 |
12 reviews available for phenol and Clasp-Knife Spasticity
| Article | Year |
|---|---|
Management of spasticity revisited.
Topics: Baclofen; Botulinum Toxins; Combined Modality Therapy; Holistic Health; Humans; Injections, Intramus | 2013 |
Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review.
Topics: Anesthetics; Botulinum Toxins, Type A; Clinical Studies as Topic; Ethanol; Humans; Muscle Spasticity | 2015 |
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diaze | 2016 |
Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity.
Topics: Botulinum Toxins; Botulinum Toxins, Type A; Humans; Muscle Denervation; Muscle Spasticity; Nerve Blo | 2009 |
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
Topics: Anti-Dyskinesia Agents; Botulinum Toxins; Central Nervous System Depressants; Drug Administration Sc | 2003 |
Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning.
Topics: Botulinum Toxins, Type A; Electromyography; Equinus Deformity; Gait; Humans; Lower Extremity; Motor | 2004 |
[Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].
Topics: Arm; Baclofen; Botulinum Toxins, Type A; Clonidine; Combined Modality Therapy; Dantrolene; Ergonomic | 2004 |
Pharmacologic interventions for reducing spasticity in cerebral palsy.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Age Factors; Anti-Infective Agents, Local; Baclofen | 2005 |
Treatment of acquired muscle spasticity using phenol peripheral nerve blocks.
Topics: Animals; Autonomic Nerve Block; Brain Injuries; Contracture; Humans; Muscle Spasticity; Neural Condu | 1995 |
Local treatment of spasticity.
Topics: Baclofen; Dantrolene; Diazepam; Humans; Muscle Spasticity; Nerve Block; Phenol; Phenols; Physical Th | 1993 |
Current status of functional lower extremity surgery in adult spastic patients.
Topics: Humans; Leg; Muscle Spasticity; Nerve Block; Phenol; Phenols; Preoperative Care | 1988 |
Management of the spastic upper extremity in the neurologically impaired adult.
Topics: Adult; Arm; Brain Injuries; Cerebrovascular Disorders; Hand; Humans; Hypoxia; Muscle Spasticity; Ner | 1988 |
Management of the spastic upper extremity in the neurologically impaired adult.
Topics: Adult; Arm; Brain Injuries; Cerebrovascular Disorders; Hand; Humans; Hypoxia; Muscle Spasticity; Ner | 1988 |
Management of the spastic upper extremity in the neurologically impaired adult.
Topics: Adult; Arm; Brain Injuries; Cerebrovascular Disorders; Hand; Humans; Hypoxia; Muscle Spasticity; Ner | 1988 |
Management of the spastic upper extremity in the neurologically impaired adult.
Topics: Adult; Arm; Brain Injuries; Cerebrovascular Disorders; Hand; Humans; Hypoxia; Muscle Spasticity; Ner | 1988 |
45 other studies available for phenol and Clasp-Knife Spasticity
| Article | Year |
|---|---|
Letter Regarding "Phenol Neurolysis for Management of Focal Spasticity in the Distal Upper Extremity".
Topics: Humans; Muscle Spasticity; Phenol; Phenols; Upper Extremity | 2020 |
Response to Letter to the Editor Regarding "Phenol Neurolysis for Management of Focal Spasticity in the Distal Upper Extremity".
Topics: Humans; Muscle Spasticity; Phenol; Phenols; Upper Extremity | 2020 |
Comparing Electrical Stimulation With and Without Ultrasound Guidance for Phenol Neurolysis to the Musculocutaneous Nerve.
Topics: Electric Stimulation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscle Spasticity; Muscu | 2018 |
The short-term effect of ultrasound and peripheral nerve stimulator-guided femoral nerve block with phenol on the outcomes of patients with traumatic spinal cord injury.
Topics: Adult; Female; Femoral Nerve; Follow-Up Studies; Humans; Lower Extremity; Male; Muscle Spasticity; N | 2018 |
Phenol Neurolysis for the Management of Shoulder Spasticity in Early Recovery From Traumatic Brain Injury: A Case Report.
Topics: Accidents, Traffic; Adolescent; Brain Injuries, Traumatic; Bursitis; Electric Stimulation; Glasgow C | 2019 |
Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain.
Topics: Botulinum Toxins; Female; Humans; Injections, Intramuscular; Middle Aged; Muscle Spasticity; Nerve B | 2013 |
Ultrasonographically guided obturator nerve block for bilateral adductor spasticity in a paraplegic patient.
Topics: Adult; Central Nervous System Agents; Humans; Male; Muscle Spasticity; Nerve Block; Obturator Nerve; | 2014 |
A Retrospective Review of Unintended Effects After Single-Event Multi-Level Chemoneurolysis With Botulinum Toxin-A and Phenol in Children With Cerebral Palsy.
Topics: Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Female; Humans; Male; Muscle Spas | 2015 |
Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
Topics: Age Factors; Anti-Dyskinesia Agents; Anti-Infective Agents, Local; Botulinum Toxins; Cerebral Palsy; | 2008 |
Neurolytic phenol blockade of the obturator nerve for severe adductor spasticity.
Topics: Adult; Female; Hip Joint; Humans; Male; Muscle Spasticity; Nerve Block; Obturator Nerve; Pain Measur | 2010 |
Drug treatments for spasticity.
Topics: Administration, Oral; Adult; Alcohols; Algorithms; Anti-Dyskinesia Agents; Baclofen; Botulinum Toxin | 2009 |
The effects of phenol neurolysis of the obturator nerve on the distribution of buttock-seat interface pressure in spinal cord injury patients with hip adductor spasticity.
Topics: Adult; Denervation; Female; Humans; Male; Middle Aged; Muscle Spasticity; Obturator Nerve; Phenol; R | 2010 |
Patient registry of outcomes in spasticity care.
Topics: Aged, 80 and over; Arm; Botulinum Toxins, Type A; Brain Injuries; Drug Therapy, Combination; Female; | 2012 |
Use of injectable spasticity management agents in a cancer center.
Topics: Botulinum Toxins, Type A; Cancer Care Facilities; Female; Humans; Injections; Male; Middle Aged; Mus | 2013 |
Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role?
Topics: Activities of Daily Living; Adult; Aged; Cross-Sectional Studies; Female; Humans; Injections, Spinal | 2002 |
[Intrathecal phenol with intractable pain and spastic conditions. A review with a report on 6 cases].
Topics: Aged; Humans; Muscle Spasticity; Ozone; Pain, Intractable; Paralysis; Phenol; Phenols | 1961 |
Intrathecal phenol in the treatment of spasticity.
Topics: Humans; Muscle Spasticity; Paralysis; Paraplegia; Phenol; Phenols; Spasm | 1962 |
Intrathecal phenol in the treatment of spastic conditions.
Topics: Humans; Muscle Spasticity; Paralysis; Paraplegia; Phenol; Phenols; Spasm | 1962 |
COMMENTS ON THE USE OF INTRASPINAL PHENOL-PANTOPAQUE FOR RELIEF OF PAIN AND SPASTICITY.
Topics: Contrast Media; Drug Therapy; Humans; Injections; Iophendylate; Leg; Muscle Spasticity; Neck; Neopla | 1963 |
MANAGEMENT OF SPASTICITY BY SELECTIVE PERIPHERAL NERVE BLOCK WITH DILUTE PHENOL SOLUTIONS IN CLINICAL REHABILITATION.
Topics: Autonomic Nerve Block; Carotid Artery Diseases; Geriatrics; Hemiplegia; Humans; Meningeal Neoplasms; | 1964 |
Use of phenol in relief of spasticity.
Topics: Humans; Muscle Spasticity; Phenol; Phenols; Spasm | 1960 |
Temporospatial parameters of gait after obturator neurolysis in patients with spasticity.
Topics: Adult; Aged; Aged, 80 and over; Female; Gait Disorders, Neurologic; Humans; Injections, Intramuscula | 2003 |
Is there evidence that botulinum toxin injections are more effective than phenol injections in relieving poststroke reflex activity during plantar flexion, thereby increasing ankle range of motion and improving gait function?
Topics: Ankle Joint; Anti-Dyskinesia Agents; Botulinum Toxins; Evidence-Based Medicine; Gait Disorders, Neur | 2004 |
Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.
Topics: Botulinum Toxins, Type A; Case-Control Studies; Cerebral Palsy; Child; Child, Preschool; Electromyog | 2004 |
Phenol reduces hypertonia and enhances strength: a longitudinal case study.
Topics: Aged; Biomechanical Phenomena; Elbow; Humans; Injections, Intramuscular; Longitudinal Studies; Male; | 2004 |
Combining botulinum toxin and phenol to manage spasticity in children.
Topics: Adolescent; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Drug Therapy, Combina | 2004 |
A comparison of the effect of doxorubicin and phenol on the skeletal muscle. May doxorubicin be a new alternative treatment agent for spasticity?
Topics: Animals; Biopsy, Needle; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Drug | 2005 |
Intrathecal phenol: an old treatment revisited.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Female; Humans; Injections, Spinal; Leg; | 2008 |
Percutaneous chemical nerve block with ultrasound-guided intraneural injection.
Topics: Adult; Arm; Feasibility Studies; Female; Humans; Injections; Leg; Lidocaine; Male; Middle Aged; Musc | 2008 |
Spastic hemiplegia in a quadriplegic patient: treatment with phenol nerve block.
Topics: Adult; Arm; Hemiplegia; Humans; Male; Muscle Spasticity; Musculocutaneous Nerve; Nerve Block; Phenol | 1984 |
Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults.
Topics: Adolescent; Adult; Animals; Craniocerebral Trauma; Dogs; Female; Forearm; Humans; Male; Movement; Mu | 1984 |
[Phenol nerve block in spasticity].
Topics: Adult; Humans; Male; Middle Aged; Muscle Spasticity; Nerve Block; Peripheral Nerves; Phenol; Phenols | 1981 |
Epidural phenol administration for iliopsoas hypertonicity.
Topics: Female; Humans; Injections, Epidural; Male; Middle Aged; Muscle Hypertonia; Muscle Spasticity; Pheno | 1995 |
Attenuation of facial muscle spasticity with intramuscular phenol neurolysis.
Topics: Eating; Facial Muscles; Humans; Hypoxia, Brain; Injections, Intramuscular; Male; Middle Aged; Muscle | 1993 |
Botox A and spasticity treatment.
Topics: Botulinum Toxins, Type A; Humans; Muscle Spasticity; Neuromuscular Agents; Phenol; Phenols; Sympatho | 1996 |
Botulinum toxin A.
Topics: Botulinum Toxins, Type A; Drug Costs; Humans; Muscle Spasticity; Neuromuscular Agents; Phenol; Pheno | 1997 |
Peripheral nerve block with phenol to treat spasticity in spinal cord injured patients.
Topics: Adult; Aged; Electric Stimulation; Female; Humans; Male; Middle Aged; Muscle Spasticity; Nerve Block | 1992 |
The use of open phenol blocks to the motor branches of the tibial nerve in adult acquired spasticity.
Topics: Adult; Craniocerebral Trauma; Female; Humans; Male; Middle Aged; Motor Neurons; Muscle Spasticity; N | 1991 |
Phenol motor point blocks in children: plasma concentrations and cardiac dysrhythmias.
Topics: Anesthesia, General; Arrhythmias, Cardiac; Child; Child, Preschool; Halothane; Humans; Muscle Spasti | 1991 |
Subscapularis motor point block for the painful hemiplegic shoulder.
Topics: Adult; Female; Hemiplegia; Hemorrhage; Humans; Male; Movement; Muscle Spasticity; Nerve Block; Pain | 1990 |
Percutaneous phenol blocks of the pectoralis major muscle to treat spastic deformities.
Topics: Humans; Muscle Spasticity; Nerve Block; Pectoralis Muscles; Phenol; Phenols; Shoulder | 1988 |
Management of intrinsic spasticity in the hand with phenol injection or neurectomy of the motor branch of the ulnar nerve.
Topics: Adolescent; Adult; Aged; Child; Female; Hand; Humans; Male; Methods; Middle Aged; Muscle Spasticity; | 1987 |
Phenol block in the treatment of spasticity.
Topics: Aged; Female; Hemiplegia; Humans; Muscle Spasticity; Nerve Block; Paresthesia; Phenol; Phenols | 1987 |
[Pharmacologic methods of controlling muscle spasticity].
Topics: Humans; Muscle Relaxants, Central; Muscle Spasticity; Phenol; Phenols | 1987 |
Phenol nerve blocks.
Topics: Hemiplegia; Humans; Muscle Spasticity; Nerve Block; Phenol; Phenols; Quadriplegia | 1985 |